Climb Bio, Inc.
- Stock
- Ticker CLYM
- Nasdaq
Performance, volatility and drawdowns of Climb Bio, Inc. since 08/2021, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $5,276. Global equities (VT): $14,653.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −96.1% in 04/2025, measured from the peak in 09/2021. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Operating income | -11 | -23 | -11 | -15 | -19 | -15 | -15 | -17 |
| EBITDA | -11 | -23 | -11 | -15 | -19 | -15 | -15 | -17 |
| Net income | -8.4 | -21 | -8.7 | -13 | -18 | -14 | -13 | -15 |
| Earnings per share | 0.04 | -0.31 | -0.13 | -0.19 | -0.25 | -0.20 | -0.18 | -0.18 |
| Balance sheet | ||||||||
| Total assets | 217 | 201 | 192 | 182 | 168 | 152 | 246 | 237 |
| Liabilities | 5.3 | 7.4 | 6.6 | 5.3 | 7.3 | 4.3 | 6.7 | 8.5 |
| Equity | 212 | 193 | 186 | 177 | 160 | 148 | 240 | 228 |
| Cash | 87 | 29 | 23 | 26 | 36 | 8.4 | 44 | 40 |
| Cash flow | ||||||||
| Operating cash flow | -5.5 | -15 | -11 | -12 | -16 | -14 | -11 | -12 |
| Capital expenditure | 0.0 | – | – | -0.1 | 0.0 | – | – | -0.8 |
| Free cash flow | -5.5 | -15 | -11 | -12 | -16 | -14 | -11 | -13 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2025 at +122.2%, weakest 2022 at −64.9%. 1 of 4 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 5 Nov 2026 | −$0.18 |
| 6 Aug 2026 | −$0.18 |
| 7 May 2026 | −$0.20 |
| 5 Mar 2026 | −$0.25 |
| 6 Nov 2025 | −$0.19 |
| 12 Aug 2025 | −$0.13 |
| 14 May 2025 | −$0.31 |
| 25 Mar 2025 | $0.04 |
| 12 Nov 2024 | −$0.13 |
| 14 Aug 2024 | −$1.81 |
| 15 May 2024 | −$0.06 |
| 28 Mar 2024 | −$0.13 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €489m
- Market cap in trading currency
- $540m
- Enterprise value
- $334m
- P/E
- –
- P/S
- –
- P/B
- 2.37
- EV/Sales
- –
- EV/EBITDA
- –
- Earnings yield
- –
- FCF yield
- -9.7%
Results (last four quarters)
- Revenue
- –
- Gross profit
- –
- EBITDA
- −$66.5m
- Net income
- −$59.3m
- Earnings per share
- −$0.81
- Revenue per share
- –
- Revenue growth
- –
- Earnings growth
- –
Profitability
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity
- -29.3%
- Return on assets
- -25.1%
Balance sheet and cash flow
- Cash
- $205m
- Cash per share
- $3.50
- Financial debt
- –
- Debt/equity %
- –
- Current ratio
- 26.58
- Book value per share
- $3.88
- Operating cash flow
- −$52.6m
- Free cash flow
- −$52.6m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- –
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 58.7m
- Volume
- 769,828
- Avg. volume 3 months
- 1.41m
- Relative volume
- 0.6
Price and technicals
- Price
- $9.19
- 1 day
- −1.0%
- 52-week high
- $17.84
- 52-week low
- $1.64
- Distance to 52-week high
- −48.5%
- Distance to 52-week low
- +460.4%
- Distance to 50-day line
- −16.6%
- Distance to 200-day line
- −14.8%
- RSI (14)
- 41
- Volatility 1M
- 108.1%
Performance
- 1 week
- −11.3%
- 1 month
- −12.8%
- 3 months
- −44.0%
- 6 months
- −16.5%
- YTD
- +129.8%
- 1 year
- +399.5%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has CLYM performed since 08/2021?
$10,000 grew to $5,780 by 20 Nov 2026, which is −9.9% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is CLYM?
Volatility was 110.3% per year, measured on monthly returns. The largest decline from a peak was −96.1%, with the low in 04/2025.
How does CLYM compare with a broad equity ETF?
Over the same period Global equities (VT) returned +7.9% per year at 15.3% volatility, CLYM returned −9.9% at 110.3%. The correlation of monthly returns was 0.09; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.